WikiMD is the world's largest medical encyclopedia with
13,854 pages, 4,142,505 edits & 40,133,090 views.
6 melanoma helper peptide vaccine
A multi-epitope vaccine containing the following six class II MHC-restricted peptides: gp100, MelanA/MART-1, two tyrosinase peptides, and the cancer/testis antigens MAGE-A3 and MAGE-A1,2,3,6, with potential antineoplastic activity. Upon administration, melanoma helper peptides induce an antigen-specific, Th1-dominant, CD4+ T-cell response, potentially augmenting cytotoxic T-cell (CTL) responses and maintaining immunologic memory against tumor cells expressing melanoma-specific antigens. The 6MHP vaccine may also induce a CD8+ T-cell response through epitope spreading, potentially priming subsequent immune responses against tumor cells.
Learn more about 6 melanoma helper peptide vaccine
- Dailymed label info
- Scientific articles
- Drug portal 6 melanoma helper peptide vaccine
- toxicity info on 6 melanoma helper peptide vaccine
- FDA 6 melanoma helper peptide vaccine
Latest research - 6 melanoma helper peptide vaccine
External links
This WikiMD article 6 melanoma helper peptide vaccine is a stub. If you are familiar with the topic 6 melanoma helper peptide vaccine, you can help us. Paid editors welcome!
6 melanoma helper peptide vaccine is part of WikiMD's free ^articles!
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
 Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available |
